Size | Price | Stock | Qty |
---|---|---|---|
1g |
|
||
2g |
|
||
5g |
|
||
10g |
|
||
25g |
|
||
100g |
|
||
Other Sizes |
|
Purity: ≥98%
Picolinamide (2-Pyridinecarboxamide, Picolinoylamide, 2-Carbamoylpyridine) is found to be a strong inhibitor of poly (ADP-ribose) synthetase of nuclei from rat pancreatic islet cells. In a prior investigation, picolinamide was employed to assess the potential correlation between the inhibition of NAD hydrolyzing enzymes and the inhibition of Na+/phosphate cotransport. The inhibition of Na+/phosphate cotransport by isolated renal brush border membrane vesicles was demonstrated by the results of an overnight picolinamide treatment of rats.
Targets |
PARP ( IC50 = 95 μM )
|
||
---|---|---|---|
ln Vitro |
|
||
ln Vivo |
|
||
Cell Assay |
It has been determined how a Gram-negative rod oxidizes picolinamide. The findings demonstrated that whole cells could release 2,5-dihydroxypyridine into culture supernatants at high pH levels. Furthermore, whole cells were able to accumulate 6-hydroxypicolinate in the culture media as a result of sodium arsenite. Furthermore, it was discovered that picolinamide oxidizes instantly in whole cells. Additionally, it was discovered that cell-free extracts were capable of hydroxylating picolinate into 6-hydroxypicolinate and converting picolinamide into picolinate.
|
||
Animal Protocol |
|
||
References |
|
Molecular Formula |
C6H6N2O
|
|
---|---|---|
Molecular Weight |
122.12
|
|
Exact Mass |
122.05
|
|
CAS # |
1452-77-3
|
|
Related CAS # |
|
|
Appearance |
Powder
|
|
SMILES |
C1=CC=NC(=C1)C(=O)N
|
|
InChi Key |
IBBMAWULFFBRKK-UHFFFAOYSA-N
|
|
InChi Code |
InChI=1S/C6H6N2O/c7-6(9)5-3-1-2-4-8-5/h1-4H,(H2,7,9)
|
|
Chemical Name |
pyridine-2-carboxamide
|
|
Synonyms |
|
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
|
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
|
|||
---|---|---|---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (20.47 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (20.47 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: ≥ 2.5 mg/mL (20.47 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 8.1887 mL | 40.9433 mL | 81.8867 mL | |
5 mM | 1.6377 mL | 8.1887 mL | 16.3773 mL | |
10 mM | 0.8189 mL | 4.0943 mL | 8.1887 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.